ON DEMAND: ACC 2022 – Australian context, international perspectives

Watch again as an expert panel present their highlights from the American College of Cardiology Annual Scientific Session and discuss the impacts for patient care. Hosted by Professor David Brieger Head of Cardiology,...

Watch again as an expert panel present their highlights from the American College of Cardiology Annual Scientific Session and discuss...
Heart failure

Mavacamten shows promise in obstructive hypertrophic cardiomyopathy

Patients with obstructive hypertrophic cardiomyopathy (HCM) may be able to avoid risky septal reduction surgery by taking the selective cardiac myosin inhibitor mavacamten, according to results presented at the American College of Cardiology’s annual meeting (ACC 2022). In a small...

Patients with obstructive hypertrophic cardiomyopathy (HCM) may be able to avoid risky septal reduction surgery by taking the selective cardiac...